Comparison of adherence and persistence with bimatoprost 0.01% versus bimatoprost 0.03% topical ophthalmic solutions

Author： Campbell Joanna H. Schwartz Gail LaBounty Britni Kowalski Jonathan Patel Vaishali D.

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.29, Iss.9, 2013-09, pp. : 1201-1209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An adherence based cost–consequence model comparing bimatoprost 0.01% to bimatoprost 0.03%

By Wong William B. Patel Vaishali D. Kowalski Jonathan W. Schwartz Gail

Current Medical Research and Opinion, Vol. 29, Iss. 9, 2013-09 ,pp. : 1191-1200

Informa Healthcare

Access to resources Recommend Favorite

Adherence, persistence and cost–consequence comparison of bimatoprost topical ocular formulations

By Alany Raid G.

Current Medical Research and Opinion, Vol. 29, Iss. 9, 2013-09 ,pp. : 1187-1189

Informa Healthcare

Access to resources Recommend Favorite

Successful Treatment of Pediatric Alopecia Areata of the Scalp Using Topical Bimatoprost

PEDIATRIC DERMATOLOGY, Vol. 33, Iss. 5, 2016-09 ,pp. : e282-e283

John Wiley & Sons Inc

Access to resources Recommend Favorite

A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma

By Martinez Antonio Sanchez Manuel

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1025-1032

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of circadian control of intraocular pressure after a single drop of bimatoprost 0.03% or travoprost 0.004%

By Frenkel Ronald E. Noecker Robert J. Craven E. Randy

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 919-923

Informa Healthcare

Access to resources Recommend Favorite